[Importance of stapolidex in infectious dermatoses].
D000152:Acne Vulgaris / Q000188:drug therapy; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002648:Child; D003907:Dexamethasone / Q000627:therapeutic use*; D004485:Eczema / Q000188:drug therapy; D011146:Eczema, Dyshidrotic / Q000188:drug therapy; D004890:Erythema / Q000188:drug therapy; D005260:Female; D006801:Humans; D007642:Keratosis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009824:Ointments / Q000627:therapeutic use; D011113:Polymyxins / Q000627:therapeutic use*; D011711:Pyoderma / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy*; D013203:Staphylococcal Infections / Q000188:drug therapy; D014769:Virginiamycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D009824:Ointments; D011113:Polymyxins; D014769:Virginiamycin; D003907:Dexamethasone
Intérêt du Stapolidex dans les dermatoses infectées.